Uppsala Akademiska Sjukhuset
Welcome,         Profile    Billing    Logout  
 4 Trials 
2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lindman, Henrik
ASCAPE, NCT04879563: Artificial Intelligence Supporting CAncer Patients Across Europe - the Project

Active, not recruiting
2
500
Europe
ASCAPE-based follow-up strategy
Region Örebro County, UBITECH, ATOS, Siemens Corporation, Corporate Technology, Intrasoft, University of Patras, FORTH - Foundation for Research and Technology Hellas, Sphynx Technology Solutions AG, Faculty of Sciences, University of Novi Sad, Serbia, DFKI - German Research Center for Artificial Intelligence, CareAcross, National and Kapodistrian University of Athens, Greece, Fundacio Clinic Barcelona, Arthur's Legal, Fundacion iSYS
Breast Cancer, Prostate Cancer, Quality of Life, Survivorship, Toxicity
06/24
06/24
Affibody-3, NCT03655353 / 2017-002115-34: A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer

Recruiting
N/A
160
Europe
ABY-PET
Henrik Lindman, Roche Pharma AG, Swedish Cancer Society, Affibody, Swedish Breast Cancer Group
HER2-positive Breast Cancer
11/24
11/25
Hellgren-Johansson, Laila
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lindman, Henrik
ASCAPE, NCT04879563: Artificial Intelligence Supporting CAncer Patients Across Europe - the Project

Active, not recruiting
2
500
Europe
ASCAPE-based follow-up strategy
Region Örebro County, UBITECH, ATOS, Siemens Corporation, Corporate Technology, Intrasoft, University of Patras, FORTH - Foundation for Research and Technology Hellas, Sphynx Technology Solutions AG, Faculty of Sciences, University of Novi Sad, Serbia, DFKI - German Research Center for Artificial Intelligence, CareAcross, National and Kapodistrian University of Athens, Greece, Fundacio Clinic Barcelona, Arthur's Legal, Fundacion iSYS
Breast Cancer, Prostate Cancer, Quality of Life, Survivorship, Toxicity
06/24
06/24
Affibody-3, NCT03655353 / 2017-002115-34: A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer

Recruiting
N/A
160
Europe
ABY-PET
Henrik Lindman, Roche Pharma AG, Swedish Cancer Society, Affibody, Swedish Breast Cancer Group
HER2-positive Breast Cancer
11/24
11/25
Hellgren-Johansson, Laila
No trials found

Download Options